177 studies found for:    Open Studies | "Psoriasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Psoriasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting IL-17 Role in Variants of Psoriasis
Conditions: Scalp Psoriasis;   Pustular Palmo-plantar Psoriasis;   Non-pustular Palmo-plantar Psoriasis;   Elbow Psoriasis;   Lower Leg Psoriasis
Intervention:
2 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
3 Recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
4 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
5 Recruiting Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
Conditions: Psoriasis;;   Psoriatic Arthritis;;   Psoriasis Arthropatica
Interventions: Drug: Apremilast;   Drug: Placebo
6 Not yet recruiting A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
7 Recruiting A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Conditions: Plaque Psoriasis;   Psoriatic Arthritis;   Pustular Psoriasis (Excluding a Localized);   Psoriatic Erythroderma
Intervention: Drug: TA-650
8 Recruiting Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Condition: Moderate to Severe Plaque-type Psoriasis
Interventions: Drug: Secukinumab (AIN457);   Drug: Placebo
9 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
10 Recruiting Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
Condition: Psoriasis
Interventions: Drug: LAS41004-IMP1;   Drug: LAS41004 IMP2;   Drug: LAS41004 IMP3;   Drug: LAS41004 IMP4;   Drug: LAS41004 IMP6;   Drug: LAS41004 IMP5
11 Recruiting Palmoplantar PustulaR Psoriasis EffiCacy and Safety wIth SEcukinumab
Condition: Palmoplantar Pustular Psoriasis
Interventions: Biological: Secucinumab;   Drug: Placebo
12 Recruiting Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis;   Psoriatic Arthritis
Interventions: Drug: Apremilast tablet/pill 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline)
13 Recruiting BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis
Condition: Psoriasis
Intervention: Other: Withdrawal of venous blood samples
14 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
15 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
16 Recruiting Comparative Analysis of Small and Large Plaque Psoriasis
Condition: Psoriasis
Interventions: Procedure: Skin biopsy;   Procedure: Blood test
17 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
18 Recruiting A Study Evaluating The Efficacy And Safety oO CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: placebo;   Drug: CP-690,550
19 Recruiting Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Conditions: Psoriasis;   Coronary Artery Disease
Intervention: Procedure: CCTA Scan (Coronary CT Angiogram)
20 Not yet recruiting TSO for Plaque Psoriasis
Condition: Plaque Psoriasis
Intervention: Biological: Trichuris Suis Ova

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years